Search
for
Sort by
Research 871–900 of 1000+
- COVID-19 and Sex Differences
- Adenomatous Polyposis Coli (APC) Is Required for Normal Development of Skin and Thymus
- The PDGF/PDGFR pathway as a drug target
- Cutaneous signs in COVID ‐19 patients: A review
- Cutaneous complications of chemotherapeutic agents
- Anthracycline analogs The past, present, and future
- Efficacy and safety of omeprazole for severe gastroesophageal reflux in children
- Superficial granulomatous pyoderma: A localized vegetative form of pyoderma gangrenosum
- K <sub>ATP</sub> Channels and Cardiovascular Disease
- Lupus erythematosus: systemic and cutaneous manifestations
- Generalized Pustular Psoriasis
- Ancient-modern concordance in Ayurvedic plants: some examples.
- Somatic stem cell heterogeneity: diversity in the blood, skin and intestinal stem cell compartments
- GABRA2 Alleles Moderate the Subjective Effects of Alcohol, Which are Attenuated by Finasteride
- Potential of Nanoparticles as Permeation Enhancers and Targeted Delivery Options for Skin: Advantages and Disadvantages
- Recognition and management of <i>Staphylococcus aureus</i> toxin‐mediated disease
- Psoriasis of the Scalp
- Isotretinoin treatment of acne and related disorders: An update
- A role of melatonin in neuroectodermal‐mesodermal interactions: the hair follicle synthesizes melatonin and expresses functional melatonin receptors
- Drug-Induced Skin, Nail and Hair Disorders
- EFFECT OF "AMINOPTERIN" ON EPITHELIAL TISSUES
- Sex differences in SARS-CoV-2 infection rates and the potential link to prostate cancer
- Ultraviolet Radiation in Wound Care: Sterilization and Stimulation
- Cutaneous reactions to recombinant cytokine therapy
- Comorbidities in alopecia areata: A systematic review and meta-analysis
- Biomedical Applications of Layer‐by‐Layer Self‐Assembly for Cell Encapsulation: Current Status and Future Perspectives
- Cutaneous reactions to chemotherapeutic drugs and targeted therapy for cancer
- Dermatoses of Pregnancy - Clues to Diagnosis, Fetal Risk and Therapy
- Polycystic Ovary Syndrome
- Immune-related alopecia (areata and universalis) in cancer patients receiving immune checkpoint inhibitors